ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 256 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $19,000 | +111.1% | 209 | +117.7% | 0.01% | +100.0% |
| Q2 2021 | $9,000 | 0.0% | 96 | +15.7% | 0.01% | 0.0% |
| Q1 2021 | $9,000 | -47.1% | 83 | -32.0% | 0.01% | -53.3% |
| Q4 2020 | $17,000 | -71.2% | 122 | -83.1% | 0.02% | -71.7% |
| Q3 2020 | $59,000 | +637.5% | 723 | +615.8% | 0.05% | +488.9% |
| Q2 2020 | $8,000 | – | 101 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |